| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9872552 | International Journal of Radiation Oncology*Biology*Physics | 2005 | 6 Pages |
Abstract
Conclusion: In a population of patients with unfavorable prognosis carcinoma of the prostate, androgen suppression applied as an adjuvant after definitive RT was associated not only with a reduction in disease progression but in a statistically significant improvement in absolute survival. The improvement in survival appeared preferentially in patients with a Gleason score of 7-10.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Miljenko V. M.D., Kathryn M.S., Colleen A. M.D., Robert E. M.D., Harvey B. M.D., Benjamin M.D., Eugen B. M.D., Sucha O. M.D., David M.D.,